Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sayeed Ikramuddin

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Iscience|December 8, 2021
A nonhuman primate model of vertical sleeve gastrectomy facilitates mechanistic and translational research in human obesityJulia L Nugent, Amar Singh, Keith M Wirth, et al.
Hepatology (Baltimore, Md.)|September 18, 2024
TREM2 macrophages mediate the beneficial effects of bariatric surgery against MASHGavin Fredrickson, Kira Florczak, Fanta Barrow, et al.
JAMA|January 18, 2018
Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery StudySayeed Ikramuddin, Judith Korner, Wei-Jei Lee, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Cyclin D1 regulates the hepatic response to feeding: Evidence for non-cell cycle roles in the liverHeng Wu, Jonathan I Hauser, Na Yang, et al.
JAMA|June 6, 2013
Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trialSayeed Ikramuddin, Judith Korner, Wei-Jei Lee, et al.
Diabetes Care|June 18, 2016
Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control TrialSayeed Ikramuddin, Judith Korner, Wei-Jei Lee, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Ketogenesis protects against MASLD-MASH progression through mechanisms that extend beyond overall fat oxidation rateEric D Queathem, David Stagg, Alisa Nelson, et al.
The Journal of Clinical Investigation|April 24, 2025
Ketogenesis mitigates metabolic dysfunction-associated steatotic liver disease through mechanisms that extend beyond fat oxidationEric D Queathem, David B Stagg, Alisa B Nelson, et al.
Obesity (Silver Spring, Md.)|December 22, 2016
Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trialShelby Sullivan, James M Swain, George Woodman, et al.
Obesity Surgery|September 8, 2012
The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesityMichael G Sarr, Charles J Billington, Roy Brancatisano, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Iscience|December 8, 2021
A nonhuman primate model of vertical sleeve gastrectomy facilitates mechanistic and translational research in human obesityJulia L Nugent, Amar Singh, Keith M Wirth, et al.
Hepatology (Baltimore, Md.)|September 18, 2024
TREM2 macrophages mediate the beneficial effects of bariatric surgery against MASHGavin Fredrickson, Kira Florczak, Fanta Barrow, et al.
JAMA|January 18, 2018
Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery StudySayeed Ikramuddin, Judith Korner, Wei-Jei Lee, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Cyclin D1 regulates the hepatic response to feeding: Evidence for non-cell cycle roles in the liverHeng Wu, Jonathan I Hauser, Na Yang, et al.
JAMA|June 6, 2013
Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trialSayeed Ikramuddin, Judith Korner, Wei-Jei Lee, et al.
Diabetes Care|June 18, 2016
Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control TrialSayeed Ikramuddin, Judith Korner, Wei-Jei Lee, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Ketogenesis protects against MASLD-MASH progression through mechanisms that extend beyond overall fat oxidation rateEric D Queathem, David Stagg, Alisa Nelson, et al.
The Journal of Clinical Investigation|April 24, 2025
Ketogenesis mitigates metabolic dysfunction-associated steatotic liver disease through mechanisms that extend beyond fat oxidationEric D Queathem, David B Stagg, Alisa B Nelson, et al.
Obesity (Silver Spring, Md.)|December 22, 2016
Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trialShelby Sullivan, James M Swain, George Woodman, et al.
Obesity Surgery|September 8, 2012
The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesityMichael G Sarr, Charles J Billington, Roy Brancatisano, et al.
Pageof 17